These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8895175)

  • 41. Intimidation of researchers by special-interest groups.
    Sternberg EM
    N Engl J Med; 1997 Oct; 337(18):1316; author reply 1316-7. PubMed ID: 9380084
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York.
    Back EE; Henning KJ; Kallenbach LR; Brix KA; Gunn RA; Melius JM
    J Rheumatol; 1993 Apr; 20(4):666-72. PubMed ID: 8496862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome.
    Horwitz RI; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():60-72. PubMed ID: 8895182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. L-tryptophan and eosinophilia-myalgia syndrome.
    Shapiro S
    Lancet; 1994 Apr; 343(8904):1035-7. PubMed ID: 7909063
    [No Abstract]   [Full Text] [Related]  

  • 45. From the Centers for Disease Control. Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.
    JAMA; 1990 Oct; 264(13):1656. PubMed ID: 2169007
    [No Abstract]   [Full Text] [Related]  

  • 46. [Eosinophilia myalgia syndrome, toxic oil syndrome].
    Niiyama T; Higuchi I
    Ryoikibetsu Shokogun Shirizu; 2001; (35):358-60. PubMed ID: 11555954
    [No Abstract]   [Full Text] [Related]  

  • 47. Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
    Cilursu AM; Goeken J; Olson RR
    Ann Rheum Dis; 1991 Nov; 50(11):817-9. PubMed ID: 1772299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
    Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. L-tryptophan and eosinophilia-myalgia syndrome.
    Mitchell N
    Med J Aust; 1993 Mar; 158(5):363-4. PubMed ID: 8329035
    [No Abstract]   [Full Text] [Related]  

  • 50. [Muscle pain, scleroderma-like skin changes and eosinophilia following administration of a psychotropic drug].
    Scheurlen C; Neubrand M; Fischer G; Soehnchen R; Kröner G; Sauerbruch T
    Internist (Berl); 1992 Apr; 33(4):269-73. PubMed ID: 1612852
    [No Abstract]   [Full Text] [Related]  

  • 51. [Peripheral neuropathy unmasked by therapy with adrenal cortex hormones during myalgia-eosinophilia syndrome related to L-tryptophan].
    Moreaud O; Mezin P; De Saint Victor JF; Noelle B; Berger F; Pellat J
    Presse Med; 1994 Jun; 23(24):1138. PubMed ID: 7971839
    [No Abstract]   [Full Text] [Related]  

  • 52. The eosinophilia-myalgia syndrome revisited.
    Belongia EA; Gleich GJ
    J Rheumatol; 1996 Oct; 23(10):1682-5. PubMed ID: 8895139
    [No Abstract]   [Full Text] [Related]  

  • 53. Eosinophilia-myalgia syndrome: lessons for public health researchers.
    Taylor R; McNeil JJ
    Med J Aust; 1993 Jan; 158(1):51-5. PubMed ID: 8380218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eosinophilia-myalgia syndrome and L-tryptophan-containing products--New Mexico, Minnesota, Oregon, and New York, 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Nov; 38(46):785-8. PubMed ID: 2509891
    [No Abstract]   [Full Text] [Related]  

  • 55. Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia.
    Margolin L
    J Rheumatol; 2003 Mar; 30(3):628-9. PubMed ID: 12610828
    [No Abstract]   [Full Text] [Related]  

  • 56. Tryptophan induced eosinophilia-myalgia syndrome: clinical and microscopic findings.
    Groves RW; Simpson KJ; Koblar S; Pitzalis C; Hay RJ
    J R Soc Med; 1992 Feb; 85(2):111-2. PubMed ID: 1538375
    [No Abstract]   [Full Text] [Related]  

  • 57. [Eosinophilia-myalgia syndrome].
    Heuschling C
    Bull Soc Sci Med Grand Duche Luxemb; 1992; 129(2):17-23. PubMed ID: 1340406
    [No Abstract]   [Full Text] [Related]  

  • 58. Delayed onset of skin fibrosis after the ingestion of eosinophilia-myalgia syndrome-associated L-tryptophan.
    Greenberg AS; Takagi H; Hill RH; Hasan A; Murata H; Falanga V
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):264-6. PubMed ID: 8708033
    [No Abstract]   [Full Text] [Related]  

  • 59. Update: eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Dec; 38(48):842-3. PubMed ID: 2511412
    [No Abstract]   [Full Text] [Related]  

  • 60. [Acute pleuropericarditis with eosinophilia after ingestion of tryptophan].
    Dell'Isola B; Rezgui N; Thiollieres JM; Labrousse J; Lissac J; Valcke JC
    Rev Med Interne; 1993 May; 14(5):353-4. PubMed ID: 8235154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.